Immunoregulation is a peer-reviewed english-language open-access journal published by Negah Institute for Social Research & Scientific Communication in Iran, Islamic Republic of, operating under an open-access model since 2018. The journal covers Medicine.
Authors publish in Immunoregulation without paying any article processing charge (APC) — making it a fully diamond/platinum open-access venue, supported entirely by its publisher or sponsor. Articles are released under the CC BY-NC license (see other journals using this license).
To date, Immunoregulation has published 102 articles. Articles are minted with DOIs through the prefix 10.32598.
Keywords
vaccine, cell therapy, immunotherapy, immunomodulation, clinical status, traditional medicine
At a glance
- Country
- Iran, Islamic Republic of
- Primary language
- English
- License
- CC BY-NC
- Peer review
- Double anonymous peer review
- OA since
- 2018
- DOI prefix
10.32598
ISSN
- 2588-5200
- electronic
- 2588-6088
Frequently asked questions
Is Immunoregulation peer-reviewed?
Yes — Immunoregulation operates a Double anonymous peer review review process.
Does Immunoregulation charge an article processing charge (APC)?
No. Immunoregulation does not charge any APC. Publication is free for accepted authors.
What subjects does Immunoregulation publish?
Immunoregulation publishes research in Medicine.
What languages does Immunoregulation accept?
Immunoregulation accepts manuscripts in English.
What is the ISSN of Immunoregulation?
ISSN:
2588-5200 (print) · 2588-6088 (electronic).How do I submit a manuscript to Immunoregulation?
Submit through the journal's official portal: visit submission page →